UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Radiation and immune checkpoint inhibitors in the treatment of oligometastatic non-small-cell lung cancer: a practical review of rationale, recent data, and research questions

Therapeutic Advances in Medical Oncology, 2023-01, Vol.15, p.17588359231183668-17588359231183668

2023

Link zum Volltext

Verfügbarkeit prüfen

The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma

Cancers, 2023-07, Vol.15 (14), p.3672

2023

Link zum Volltext

Verfügbarkeit prüfen

A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma

Radiation oncology (London, England), 2018-03, Vol.13 (1), p.47-8, Article 47

2018

Link zum Volltext

Verfügbarkeit prüfen

Stereotactic Body Radiotherapy: Hitting Harder, Faster, and Smarter in High-Risk Prostate Cancer

Frontiers in oncology, 2022-07, Vol.12, p.889132-889132

2022

Link zum Volltext

Verfügbarkeit prüfen

Stereotactic Radiotherapy as a Treatment Option for Renal Tumors in the Solitary Kidney: A Multicenter Analysis from the IROCK

The Journal of urology, 2019-06, Vol.201 (6), p.101097JU0000000000000111-1104

2019

Link zum Volltext

Verfügbarkeit prüfen

Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids

Carcinogenesis (New York), 2012, Vol.33 (1), p.49-58

2012

Link zum Volltext

Verfügbarkeit prüfen

Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids

Oncotarget, 2015-09, Vol.6 (26), p.22424-22438

2015

Link zum Volltext

Verfügbarkeit prüfen

Remote Contouring and Virtual Review during the COVID-19 Pandemic (RECOVR-COVID19): Results of a Quality Improvement Initiative for Virtual Resident Training in Radiation Oncology

Current oncology (Toronto), 2021-08, Vol.28 (4), p.2961-2968

2021

Link zum Volltext

Verfügbarkeit prüfen

Can a FLAME forge a stronger SABRe? Let’s await the evidence for focal boost with Stereotactic Ablative Radiotherapy

Radiotherapy and oncology, 2022-09, Vol.174, p.173-174

2022

Link zum Volltext

Verfügbarkeit prüfen

Overcoming the Challenges of High Quality RNA Extraction from Core Needle Biopsy

Biomolecules (Basel, Switzerland), 2021-04, Vol.11 (5), p.621

2021

Link zum Volltext

Verfügbarkeit prüfen

Beclin-1 expression is retained in high-grade serous ovarian cancer yet is not essential for autophagy induction in vitro

Journal of ovarian research, 2015-08, Vol.8 (1), p.52, Article 52

2015

Link zum Volltext

Verfügbarkeit prüfen

Stereotactic Ablative Radiotherapy for ≥T1b Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK)

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (4), p.941-949

2020

Link zum Volltext

Verfügbarkeit prüfen

Should stereotactic ablative body radiotherapy be the standard of care in oligometastatic cancer?

The lancet oncology, 2021-01, Vol.22 (1), p.6-8

2021

Link zum Volltext

Verfügbarkeit prüfen

BMP signalling controls the malignant potential of ascites-derived human epithelial ovarian cancer spheroids via AKT kinase activation

Clinical & experimental metastasis, 2012-04, Vol.29 (4), p.293-313

2012

Link zum Volltext

Verfügbarkeit prüfen

Radiation in the Treatment of Oligometastatic and Oligoprogressive Disease: Rationale, Recent Data, and Research Questions

The cancer journal (Sudbury, Mass.), 2020-03, Vol.26 (2), p.156

2020

Link zum Volltext

Verfügbarkeit prüfen

Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?

Radiotherapy and oncology, 2022-04, Vol.169, p.51-56

2022

Link zum Volltext

Verfügbarkeit prüfen

Stereotactic Body Radiotherapy for Oligometastasis: Opportunities for Biology to Guide Clinical Management

The cancer journal (Sudbury, Mass.), 2016-07, Vol.22 (4), p.247

2016

Link zum Volltext

Verfügbarkeit prüfen

Intraluminal Superior Vena Cava Invasion

Journal of thoracic oncology, 2020-01, Vol.15 (1), p.144-145

2020

Link zum Volltext

Verfügbarkeit prüfen

Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability

Carcinogenesis (New York), 2014-09, Vol.35 (9), p.1951-1961

2014

Link zum Volltext

Verfügbarkeit prüfen

Stereotactic Ablative Radiotherapy (SABR) for Large Renal Tumors: A Retrospective Case Series Evaluating Clinical Outcomes, Toxicity, and Technical Considerations

American journal of clinical oncology, 2018-06, Vol.41 (6), p.568-575

2018

Link zum Volltext

Verfügbarkeit prüfen

A Framework for Assuring the Safety, Training, Evaluation, and Wellness of Radiation Oncology Residents During the COVID-19 Pandemic (ASTEROiD-COVID19)

Advances in radiation oncology, 2021-09, Vol.6 (5), p.100754-100754, Article 100754

2021

Link zum Volltext

Verfügbarkeit prüfen

Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity

Gynecologic oncology, 2012-05, Vol.125 (2), p.441-450

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Oncology
(26)
Humans
(21)
Female
(11)
Male
(10)
Tumors
(7)
Carcinoma, Renal Cell - Radiotherapy
(6)
Metastasis
(6)
Radiation Therapy
(6)
Radiology, Nuclear Medicine & Medical Imaging
(6)
Radiosurgery
(6)
Radiosurgery - Adverse Effects
(6)
Radiosurgery - Methods
(6)
Renal Cell Carcinoma
(6)
Aged
(5)
Kidney Neoplasms - Radiotherapy
(5)
Metastases
(5)
Ovarian Neoplasms - Pathology
(5)
Abdomen
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial

Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial

Radiation and immune checkpoint inhibitors in the treatment of oligometastatic non-small-cell lung cancer: a practical review of rationale, recent data, and research questions

The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma

A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma

Stereotactic Body Radiotherapy: Hitting Harder, Faster, and Smarter in High-Risk Prostate Cancer

Stereotactic Radiotherapy as a Treatment Option for Renal Tumors in the Solitary Kidney: A Multicenter Analysis from the IROCK

Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids

Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids

Remote Contouring and Virtual Review during the COVID-19 Pandemic (RECOVR-COVID19): Results of a Quality Improvement Initiative for Virtual Resident Training in Radiation Oncology

Can a FLAME forge a stronger SABRe? Let’s await the evidence for focal boost with Stereotactic Ablative Radiotherapy

Overcoming the Challenges of High Quality RNA Extraction from Core Needle Biopsy

Beclin-1 expression is retained in high-grade serous ovarian cancer yet is not essential for autophagy induction in vitro

Stereotactic Ablative Radiotherapy for ≥T1b Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK)

Should stereotactic ablative body radiotherapy be the standard of care in oligometastatic cancer?

5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney)

BMP signalling controls the malignant potential of ascites-derived human epithelial ovarian cancer spheroids via AKT kinase activation

Radiation in the Treatment of Oligometastatic and Oligoprogressive Disease: Rationale, Recent Data, and Research Questions

Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?

Stereotactic Body Radiotherapy for Oligometastasis: Opportunities for Biology to Guide Clinical Management

Intraluminal Superior Vena Cava Invasion

Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability

Stereotactic Ablative Radiotherapy (SABR) for Large Renal Tumors: A Retrospective Case Series Evaluating Clinical Outcomes, Toxicity, and Technical Considerations

A Framework for Assuring the Safety, Training, Evaluation, and Wellness of Radiation Oncology Residents During the COVID-19 Pandemic (ASTEROiD-COVID19)

Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity

Suchergebnisse filtern